MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Novartis AG Common Stock (NY:NVS)

150.75 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Mar 25, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,907
Open 150.75
Bid (Size) 150.25 (400)
Ask (Size) 150.35 (400)
Prev. Close 150.75
Today's Range 150.75 - 150.75
52wk Range 97.72 - 170.46
Shares Outstanding N/A
Dividend Yield 2.65%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
The $6.7 Billion Pivot: A Deep Dive into Terns Pharmaceuticals (TERN) and the Merck Acquisition
On this Wednesday, March 25, 2026, the biotechnology sector has been electrified by the announcement that Merck & Co. (NYSE: MRK) will acquire Terns Pharmaceuticals, Inc. (NASDAQ: TERN) in an all-cash... 
Via Finterra
Topics Initial Public Offering Intellectual Property World Trade
News headline image
Retirees: Collect a High Dividend While Diversifying Your Portfolio With This ETF ↗
The Vanguard International High Dividend Yield ETF holds more than 1,500 stocks and yields 3.3%. 
Via The Motley Fool
Topics ETFs Retirement

Performance

YTD
+8.8%
+8.8%
1 Month
-8.5%
-8.5%
3 Month
+8.5%
+8.5%
6 Month
+22.6%
+22.6%
1 Year
+36.6%
+36.6%

More News

Read More
News headline image
3 ETFs Built for the Volatile Market We're Seeing in March 2026 ↗
Via The Motley Fool
Topics ETFs Economy Stocks
Novartis AG-Sponsored ADR (NYSE:NVS): A Methodical Pick for Steady Dividend Income ↗
Via Chartmill
Novartis AG-Sponsored ADR (NYSE:NVS): A Quality Dividend Stock with Strong Fundamentals ↗
Via Chartmill
News headline image
Novartis Strikes $3 Billion Deal For Next-Gen Breast Cancer Drug ↗
Via Benzinga
News headline image
The High-Stakes Gambit: How Healthcare Giants are 'Front-Loading' Megadeals to Outrun Regulatory Storms
Via MarketMinute
Topics Artificial Intelligence Intellectual Property
News headline image
Novartis Advances Dermatology Portfolio With Cosentyx FDA Approval For Pediatric Patients ↗
Via Benzinga
News headline image
VYMI: This International ETF Could Help You Earn Higher Dividends ↗
Via The Motley Fool
Topics ETFs
News headline image
3 ETFs to Avoid as Oil Shock Hits Markets ↗
Via MarketBeat
Topics ETFs
News headline image
Vertex Pharmaceuticals Surges as Breakthrough Kidney Data Sets New Gold Standard for IgA Nephropathy
Via MarketMinute
News headline image
Pfizer (PFE) 2026 Research Feature: The High-Stakes Pivot to Oncology and Obesity
Via Finterra
Topics Economy Intellectual Property Lawsuit
News headline image
Forget Amarin: This Oft-Overlooked Pharma Powerhouse Is a Better Buy Now ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
As Investors Flee U.S. Equities, This Global ETF Is Outperforming ↗
Via MarketBeat
Topics ETFs
News headline image
Second HeLa Lawsuit Resolved As Novartis Reaches Confidential Settlement ↗
Via Benzinga
Topics Lawsuit
News headline image
Pfizer Secures Full FDA Approval for BRAFTOVI in First-Line Colorectal Cancer, Bolstering Oncology Growth Strategy
Via MarketMinute
Topics Economy Intellectual Property
News headline image
Stock Market Today, Feb. 25: Novo Nordisk Dips After Announcing $2.1 Billion Partnership With Vivtex for Oral Drug-Delivery Technologies ↗
Via The Motley Fool
Topics Stocks
News headline image
Eli Lilly Bolsters Genetic Medicine Portfolio with $2.4 Billion Acquisition of Orna Therapeutics
Via MarketMinute
Topics Intellectual Property
News headline image
Could Novartis Stock Quietly Help You Build a Millionaire Retirement Portfolio? ↗
Via The Motley Fool
Topics Intellectual Property Retirement
News headline image
Arvinas (ARVN) Q4 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Stock Market Today, Feb. 23: Novo Nordisk Plunges 16% After Obesity Drug Falls Short ↗
Via The Motley Fool
Topics Stocks
News headline image
Novartis: This Big Pharma Giant Could Be a Sleep‑at‑Night Core Holding for Decades ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Pfizer’s BRAFTOVI BREAKWATER Trial Delivers Landmark Survival Gains in Colorectal Cancer
Via MarketMinute
News headline image
A Look Into Novartis Inc's Price Over Earnings ↗
Via Benzinga
News headline image
Promethos Capital Liquidates $4 Million Sprouts Farmers Market Position: Should Investors Sell, Too? ↗
Via The Motley Fool
Topics Regulatory Compliance

Frequently Asked Questions

Is Novartis AG Common Stock publicly traded?
Yes, Novartis AG Common Stock is publicly traded.
What exchange does Novartis AG Common Stock trade on?
Novartis AG Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novartis AG Common Stock?
The ticker symbol for Novartis AG Common Stock is NVS on the New York Stock Exchange
What is the current price of Novartis AG Common Stock?
The current price of Novartis AG Common Stock is 150.75
When was Novartis AG Common Stock last traded?
The last trade of Novartis AG Common Stock was at 03/25/26 07:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story